Angstrom Pharmaceuticals
Solana Beach
About Angstrom Pharmaceuticals
Angstrom Pharmaceuticals develops new class of drugs targeting CD44 for the treatment of metastatic diseases and hematological malignancies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Series Unknown (Sep 2003)
- Website: angstrominc.com
Industries & Categories
Biotechnology, Clinical Trials, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/angstrom-pharmaceuticals-365041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.